JB Chemicals & Pharmaceuticals Ltd announced on Friday, March 14, that its API (Active Pharmaceutical Ingredient) manufacturing facility (D9) in Panoli, Gujarat, has successfully cleared a US Food and Drug Administration (USFDA) inspection with no observations. Zero Observations from USFDA The inspection, conducted from March 10 to March 13, 2025, concluded without any Form 483 …